Skip to main content

Lucentis 0.5 mg/0.05 mL (10 mg/mL) injection Images

Generic Name: ranibizumab

This medication has been identified as Lucentis 0.5 mg/0.05 mL (10 mg/mL) injection and is used for Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Myopic Choroidal Neovascularization. It belongs to the drug class anti-angiogenic ophthalmic agents and is not a controlled substance.

Images of medication

Lucentis 0.5 mg/0.05 mL (10 mg/mL) injection medicine

Lucentis

Generic Name
ranibizumab
Strength
0.5 mg/0.05 mL (10 mg/mL) injection
Availability
Prescription only
Drug Class
Anti-angiogenic ophthalmic agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0080

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.